Recombinant Human APBA3 Protein, His-tagged
Cat.No. : | APBA3-198H |
Product Overview : | Recombinant Human APBA3 Protein (Asp23-Leu278) with N-His tag was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Description : | The protein encoded by this gene is a member of the X11 protein family. It is an adapter protein that interacts with the Alzheimer's disease amyloid precursor protein. This gene product is believed to be involved in signal transduction processes. This gene is a candidate gene for Alzheimer's disease. |
Source : | E. coli |
Species : | Human |
Tag : | N-His |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 31.0 kDa |
Protein length : | Asp23-Leu278 |
Purity : | > 97% |
Applications : | Positive Control; Immunogen; SDS-PAGE; WB. |
Stability : | The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 centigrade for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8 centigrade for one month. Aliquot and store at -80 centigrade for 12 months. |
Storage Buffer : | PBS, pH7.4, containing 0.01% SKL, 1 mM DTT, 5% Trehalose and Proclin300. |
Reconstitution : | Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL. Do not vortex. |
Gene Name : | APBA3 amyloid beta (A4) precursor protein-binding, family A, member 3 [ Homo sapiens (human) ] |
Official Symbol : | APBA3 |
Synonyms : | APBA3; amyloid beta (A4) precursor protein-binding, family A, member 3; amyloid beta A4 precursor protein-binding family A member 3; mint3; X11 like 2; X11L2; mint-3; X11-like 2 protein; adapter protein X11gamma; neuron-specific X11L2 protein; neuronal munc18-1-interacting protein 3; phosphotyrosine-binding/-interacting domain (PTB)-bearing protein; amyloid beta (A4) precursor protein-binding, family A, member 3 (X11-like 2); MGC:15815 |
Gene ID : | 9546 |
mRNA Refseq : | NM_004886 |
Protein Refseq : | NP_004877 |
MIM : | 604262 |
UniProt ID : | O96018 |
Products Types
◆ Recombinant Protein | ||
APBA3-614M | Recombinant Mouse APBA3 Protein, His (Fc)-Avi-tagged | +Inquiry |
APBA3-365R | Recombinant Rat APBA3 Protein, His (Fc)-Avi-tagged | +Inquiry |
APBA3-2316H | Recombinant Human APBA3 Protein, MYC/DDK-tagged | +Inquiry |
Apba3-8067M | Recombinant Mouse Apba3 protein, His & T7-tagged | +Inquiry |
Apba3-3436M | Recombinant Mouse Apba3, His-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (10)
Ask a questionThe application prospects of APBA3 in neurodegenerative diseases are still uncertain, but its involvement in synaptic transmission and neurotransmitter regulation may have potential value in the treatment of such diseases.
Yes, the APBA3 protein can interact with other proteins, including those involved in synaptic transmission and neurotransmitter regulation.
Recombinant APBA3 protein has potential clinical applications, including neurodegenerative diseases, cognitive disorders and cancer treatment.
The side effects of APBA3 are currently unclear and require further clinical studies and validation.
APBA3 protein is a multi-domain protein whose main function is to participate in the regulation of signal transduction and synaptic transmission of neurotransmitters.
Recombinant APBA3 may have a positive effect on cognitive function, improving cognition by regulating synaptic transmission and neurotransmitter balance.
At present, the clinical trial of APBA3 is under way, and the specific progress needs to consult the relevant clinical research institutions.
The mechanism of action of APBA3 in cancer therapy is not clear, but some studies suggest that it may be involved in the regulation of signal transduction pathways, thereby inhibiting tumor growth and metastasis.
Whether the recombinant APBA3 protein can be administered orally to patients still needs further study. At present, it is mainly administered by injection.
Recombinant APBA3 proteins are usually synthesized in cells by genetic engineering techniques and then purified and purified, for example using affinity chromatography.
Customer Reviews (4)
Write a reviewThe short half-life and high clearance characteristics of APBA3 allow it to better interact with other drugs, so as to better play the effect of combination therapy.
Green production process of APBA3 realizes the efficient use of energy, reduces energy consumption, reduces carbon emissions, and is very friendly to the environment.
APBA3 is highly stable and reproducible, which brings great convenience to our experiments. The results of each experiment are very consistent, giving us more confidence in its quality and reliability.
Stability of APBA3 is very good, and the results remain consistent after repeated use, showing good product quality.
Ask a Question for All APBA3 Products
Required fields are marked with *
My Review for All APBA3 Products
Required fields are marked with *
Inquiry Basket